TrueTMS Competitors

Stony Brook Medicine expresses our shared mission of research, clinical care and education – a mission embraced by our faculty, staff, researchers, and students. It is the embodiment of everything we do on behalf of the health of patients – not only here in our community, but also in the region and worldwide. Stony Brook Medicine comprises five Health Sciences schools — Renaissance School of Medicine, School of Dental Medicine, School of Health Technology and Management, School of Nursing and School of Social Welfare — as well as Stony Brook University Hospital, Stony Brook Southampton Hospital, Stony Brook Eastern Long Island Hospital, Stony Brook Children’s Hospital and more than 200 community-based healthcare settings throughout Suffolk County. Our health sciences schools work in tandem with our research and clinical care teams to deliver the best ideas in medicine to patients. As an academic medical center, we are all about ideas. Creating them. Nurturing them. Protecting them. Challenging them. Improving them. Teaching them to others. And most importantly of all, delivering them to patients and their families – sooner, smarter and better. An “idea” can be a new treatment protocol, best practices, a bright new researcher we’ve brought in from another institution, the convenience of an outpatient clinic, or simply a more user-friendly way to access our medical care. Ideas drive us, they thrive here, and we are committed to bringing more of them to our patients than anyone else.

Neuronetics, Inc., is the creator of NeuroStar Advanced Therapy, the market leader in Transcranial Magnetic Stimulation (TMS) for the treatment of Major Depressive Disorder. Based in Malvern, PA, we are a public medical device company (STIM) with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world. NeuroStar is the #1 TMS choice of doctors, with over 4.3 million treatments performed to date. It is an advanced treatment for depression. It is not medication, shock therapy, or surgery. NeuroStar is an outpatient treatment done in as little as 20 minutes for 36 sessions. It promotes neuroplasticity to target depression where it starts — the brain. Neuronetics markets NeuroStar Advanced Therapy throughout the United States and select markets around the world. If you have questions or comments about NeuroStar, please e-mail us at customersupport@neurostar.com. For U.S. phone support, please call us at (877) 600-7555, for international customers, our number is +1 (610) 640-4207. Please visit NeuroStar.com/Safety for full safety and prescribing information.

Mindful Health Solutions is one of the nation’s leading providers of innovative behavioral health care with a focus on emerging psychedelic research, precision medicine, and cutting-edge treatment protocols such as TMS, Esketamine, and IV Ketamine for patients struggling with treatment-resistant depression and other psychiatric illnesses. We founded one of the first TMS-focused clinics in the US and have deep expertise in the field of non-invasive brain stimulation. We then went on to establish one of the first clinics to provide Esketamine (Spravato) therapy at scale, and recently incorporated IV Ketamine into our depression treatment pathway. Patients at Mindful Health Solutions have access to true thought leaders in the field focused on bringing academic rigor and years of experience with novel therapeutics to an integrated treatment strategy. We are currently leaning into the promise of psychedelic therapies for depression and PTSD as well as leveraging our extensive clinical outcomes repository to develop predictive algorithms that will help guide our clinicians in selecting the best treatment modality for their patients. We have grown to 22 outpatient clinics located in California, Texas, and Washington and continue to expand our innovative, precision-medicine platform into new markets.